Follicular Lymphoma

• FDA label_change · 2022-06-30
  FDA Approved: LENALIDOMIDE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

  FDA approved a supplemental application for lenalidomide submitted by Dr. Reddy's Laboratories Inc., resulting in updated labeling for the d…

• FDA label_change · 2019-10-08
  FDA Approved: BENDEKA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

  FDA approved a supplemental application for Bendeka (bendamustine hydrochloride) by Teva Pharmaceuticals to update its labeling.

• FDA label_change · 2011-10-28
  FDA Approved: LEUKERAN — Supplemental Application (Waylis Therapeutics LLC)

  FDA supplemental application for Leukeran (chlorambucil) submitted by Waylis Therapeutics LLC.

• FDA label_change · 2007-11-02
  FDA Approved: ZEVALIN — Supplemental Application (Acrotech Biopharma Inc)

  FDA granted approval of a supplemental application for Zevalin (ibrutinomab tiuxetan) submitted by Acrotech Biopharma, resulting in updated …